Purines in the eye: Recent evidence for the physiological and pathological role of purines in the RPE, retinal neurons, astrocytes, Müller cells, lens, trabecular meshwork, cornea and lacrimal gland  by Sanderson, Julie et al.
lable at ScienceDirect
Experimental Eye Research 127 (2014) 270e279Contents lists avaiExperimental Eye Research
journal homepage: www.elsevier .com/locate/yexerReviewPurines in the eye: Recent evidence for the physiological and
pathological role of purines in the RPE, retinal neurons, astrocytes,
Müller cells, lens, trabecular meshwork, cornea and lacrimal gland
Julie Sanderson a, Darlene A. Dartt b, Vickery Trinkaus-Randall c, d, Jesus Pintor e,
Mortimer M. Civan f, g, Nicholas A. Delamere h, i, Erica L. Fletcher j, Thomas E. Salt k,
Antje Grosche l, Claire H. Mitchell f, m, *
a School of Pharmacy, University of East Anglia, Norwich, UK
b Schepens Eye Research Institute/Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA
c Department of Ophthalmology, Boston University School of Medicine, Boston, MA, USA
d Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA
e Department of Biochemistry, Faculty of Optometry, Universidad Complutense de Madrid, Madrid, Spain
f Department of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
g Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
h Department of Physiology, University of Arizona, Tucson, AZ, USA
i Department of Ophthalmology and Vision Science, University of Arizona, Tucson, AZ, USA
j Department of Anatomy and of Neuroscience, University of Melbourne, Victoria, Australia
k Department of Visual Neuroscience, UCL Institute of Ophthalmology, London, UK
l Institute of Human Genetics, Franz-Josef-Strauß-Allee, Regensburg, Germany
m Department of Anatomy and Cell Biology, University of Pennsylvania, Philadelphia, PA, USAa r t i c l e i n f o
Article history:
Received 28 May 2014
Accepted in revised form 12 August 2014
Available online 20 August 2014
Keywords:
neurotransmitter
eye
P2X
P2Y
adenosine
ATP
retina
lens
trabecular meshwork
cornea
RPE
lacrimal gland
diadenosine polyphosphates* Corresponding author. Department of Anatomy an
573 2176.
E-mail address: chm@exchange.upenn.edu (C.H. M
http://dx.doi.org/10.1016/j.exer.2014.08.009
0014-4835/© 2014 The Authors. Published by Elseviera b s t r a c t
This review highlights recent ﬁndings that describ how purines modulate the physiological and patho-
physiological responses of ocular tissues. For example, in lacrimal glands the cross-talk between P2X7 re-
ceptors and both M3 muscarinic receptors and a1D-adrenergic receptors can inﬂuence tear secretion. In the
cornea, purines lead to post-translational modiﬁcation of EGFR and structural proteins that participate in
wound repair in the epithelium and inﬂuence the expression ofmatrix proteins in the stroma. Purines act at
receptors on both the trabecular meshwork and ciliary epithelium to modulate intraocular pressure (IOP);
ATP-release pathways of inﬂow and outﬂow cells differ, possibly permitting differential modulation of
adenosine delivery. Modulators of trabecular meshwork cell ATP release include cell volume, stretch,
extracellular Ca2þ concentration, oxidation state, actin remodeling and possibly endogenous cardiotonic
steroids. In the lens, osmotic stress leads toATP release following TRPV4activationupstreamofhemichannel
opening. In the anterior eye, diadenosine polyphosphates such as Ap4A act at P2 receptors to modulate the
rate and compositionof tear secretion, impact cornealwoundhealing and lower IOP. TheGq11-coupled P2Y1-
receptor contributes to volume control in Müller cells and thus the retina. P2X receptors are expressed in
neurons in the inner and outer retina and contribute to visual processing as well as the demise of retinal
ganglion cells. In RPE cells, the balance between extracellular ATP and adenosine may modulate lysosomal
pH and the rate of lipofuscin formation. In optic nerve head astrocytes, mechanosensitive ATP release via
pannexinhemichannels, coupledwith stretch-dependent upregulationof pannexins, provides amechanism
for ATP signaling in chronic glaucoma.With somany receptors linked to divergent functions throughout the
eye, ensuring the transmitters remain local and stimulation is restricted to the intended target may be a key
issue in understanding how physiological signaling becomes pathological in ocular disease.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).d Cell Biology, University of Pennsylvania, 440 Levy Building, 240 S. 40th St, Philadelphia, PA 19104, USA. Tel.: þ1 215
itchell).
Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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The purines ATP, adenosine, and diadenosine polyphosphates
(Fig. 1), along with their metabolites and pyrimidine analogs,
mediate a large number of functions in the eye.While some of these
activities are required for the daily maintenance of ocular tissue,
there is a growing recognition that dysregulated stimulation can
contribute to disease. This review discusses recent developments in
several ocular tissues involving both basic signaling and contribu-
tion to disease.
The fundamentals of purinergic signaling in the eye are
common throughout the body. While ATP can be released by
nerves as a classic neurotransmitter, purinergic signaling sys-
tems are particularly interesting because nearly all cell types
release ATP. The use of vesicular, non-vesicular or a mixture of
both release mechanisms by these cells enables local delivery of
the transmitter and allows the transmitter release to be more
responsive to local cues (Fitz, 2007). This released ATP is
dephosphorylated into ADP, AMP and adenosine by ectonucleo-
tidases and ectoATDPases. ATP acts at ionotropic P2X receptors
or metabotropic P2Y receptors, while adenosine acts at metab-
otropic receptors (Burnstock, 2006). Critically, the locally
released ATP acts in an autocrine and paracrine fashion to
maintain homeostasis as well as respond to insults (Corriden and
Insel, 2010).Fig. 1. Basic structure of endogenous purinergic agonists. Structures of A. Adenosine 5' tr
tetraphosphate (Ap4A).
Fig. 2. Sites of purinergic inﬂuence in the eye that are discussed in this review. Purinergic
trabecular meshwork is expanded in Fig. 4, in the lens in Fig. 5, in the retina in Fig. 6, andWhile ocular tissues have been known for over a decade to
possess purinergic receptors and respond to stimulation, the ﬁeld
has moved far beyond receptor identiﬁcation in the past few years.
Below we highlight recent key advances in ocular purine research
and stress the complexities and nuances of purinergic signaling.
From interactions with other transmitter systems and differential
effects of splice variants on the ocular surface, different mecha-
nisms of ATP release from lens and trabecular meshwork, and the
effects of diadenosine polyphosphates in the anterior eye, to the
manipulation of Müller cell volume, purinergic contributions of
ATP to visual processing in the inner and outer retina, survival of
retinal ganglion cells and manipulation of lysosomal pH and lip-
ofuscin levels in RPE cells, the review draws attention to recent
advances that push our understanding of how purinergic signaling
inﬂuences the eye. A graphical overview of the ocular regions dis-
cussed in this review is given in Fig. 2.
This review represents interesting recent work by some of the
key researchers in the ﬁeld of ocular purines; it is not meant an
exhaustive review of the ﬁeld. There are several exciting areas of
research in ocular purines that are not discussed including devel-
opment (Pearson et al., 2005), glial cells (Newman, 2004), pericytes
(Sugiyama et al., 2005), photoreceptor survival (Notomi et al.,
2011), A1 adenosine receptors and outﬂow (Crosson et al., 2005),
and many others. It is hoped that future reviews will be able to
capture the excitement of these additional ﬁelds.iphosphate (ATP); B. Uridine 5'triphosphate (UTP); C. Adenosine and; D. Diadenosine
signaling in the conjunctiva, lacrimal gland and cornea is expanded in Fig. 3, in the
Müller cells in Fig. 7.
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2.1. Purinergic signaling in the lacrimal gland: cross-talk between
P2X7, M3 muscarinic, and a1D-adrenergic receptors
A decrease in the amount or change in the composition of
lacrimal gland ﬂuid secretion can lead to dry eye disease. Lacrimal
gland secretion consists of proteins, electrolytes, and water that is
regulated predominantly by activation of parasympathetic and
sympathetic nerves (Dartt, 2009). An additional stimulus for
secretion is ATP acting at purinergic receptors (Hodges et al., 2009;
Novak et al., 2010) suggesting neuromodulatory or autocrine
function of purines inﬂuence lacrimal secretion. Freshly isolated rat
lacrimal gland acini have been used to determine the cellular in-
teractions between purinergic receptors, M3 muscarinic receptors
(Dartt and Hodges, 2011a) and a1D-adrenergic receptors (Dartt and
Hodges, 2011b), and how they inﬂuence protein secretion (Fig. 3).
In the lacrimal gland ATP activates P2X3 and P2X7 receptors to
increase intracellular calcium ([Ca2þ]i) and stimulate protein secre-
tion (Hodges et al., 2011, 2009; Novak et al., 2010). When the inter-
action between P2X7 andM3muscarinic receptors was investigated,
cholinergic agonists were found to release ATP from lacrimal gland
pieces, but not isolated acini, suggesting that cholinergic agonists
may stimulate ATP release from efferent nerve endings rather than
from the acinar and duct cells themselves (Dartt andHodges, 2011a).
Using muscarinic and P2X7 agonists and antagonists on acinar cells,
muscarinicagonistswere found toactivateP2X7 receptors to increase
[Ca2þ]i and stimulate protein secretion, whereas P2X7 agonists did
not activate M3 muscarinic receptors. As the latter measurementsFig. 3. Purines in the lacrimal gland and cornea. Schematic of ocular surface with mechanis
acini (top) and growth faction and nucleotide interaction to cause corneal epithelial wo
phospholipase C, PKC-protein kinase C, PLD-phospholipase D, ERK1/2-extracellular regula
-a1D adrenergic receptor, norepi-norepinephrine, NO-nitric oxide, cGMP-cyclic guanosine m
P2X3-purinergic receptor X3, TGFa-transforming growth factor a.were made in acini, muscarinic agonists are not activating P2X7 re-
ceptors by releasing ATP (Dartt and Hodges, 2011a); rather musca-
rinic agonists are activating an intracellular signaling pathway. The
signaling components of this pathway remain to be identiﬁed, but
activation of protein kinase C (PKC) a or ε has been eliminated.
The interaction between P2X7 and a1D-adrenergic receptors was
subsequently investigated (Dartt and Hodges, 2011b). This inter-
action was different from the P2X7/M3 muscarinic receptor inter-
action. First the a1D-adrenergic receptor agonist phenylephrine
caused ATP release from both lacrimal gland pieces and acini.
Second, using agonists and antagonists, activation of a1D-adren-
ergic receptors was also found to activate P2X7 receptors. This
caused only an increase in [Ca2þ]i, but not in protein secretion.
Third, activation of P2X7 receptors also activated a1D-adrenergic
receptors causing an increase in [Ca2þ]iI, but not in protein secre-
tion (Dartt and Hodges, 2011b).
To determine if the interaction of a1D-adrenergic receptors with
P2X7 receptors was relevant for protein secretion, P2X7 receptor
knockout mice were examined. In the absence of P2X7 receptors
a1D-adrenergic agonist-stimulated protein secretion was
decreased. This suggests an important interaction between a1D-
adrenergic and P2X7 receptors. In the same knockout mice, M3
muscarinic agonist stimulated secretion was unchanged. This
ﬁnding is consistent with M3 muscarinic agonists stimulating P2X7
receptors, but not the reverse. The results with P2X7 receptor
knockout mice in which protein secretion was decreased or un-
changed suggests that activation of P2X7 receptors is beneﬁcial for
lacrimal gland secretion and that P2X7 receptors are not deleterious
in the lacrimal gland.ms of purinergic, muscarinic, and a-adrenergic pathway interactions in lacrimal gland
und healing (bottom). Ach-acetylcholine, M3 AChR-muscarinic type 3 receptor, PLC-
ted kinase 1/2. ATP-adenosine triphosphate, P2X7R-purinergic receptor X7, a1D-AR
onophosphate, EGF-epidermal growth factor, EGFR-epidermal growth factor receptor,
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interact with P2X7 receptors to increase [Ca2þ]i and stimulate
protein secretion in the lacrimal gland, however the cellular
mechanisms of interaction differ (Fig. 3). M3 muscarinic receptors
use an intracellular pathway to stimulate P2X7 receptors, whereas
a1D-adrenergic receptors release ATP from acinar cells and a1D-
adrenergic and P2X7 receptors activate each other. P2X7 receptor
activation is not deleterious in the lacrimal gland.
2.2. Purine signaling in the cornea: a role in wound repair
The avascular and highly innervated cornea is divided into 3
regions by 2 basement membranes: epithelium, a matrix-rich
stroma, and endothelium. Trigeminal cultures express the full
complement of P2Yand P2X receptors while corneal epithelial cells
express select P2Y (Boucher et al., 2011, 2010; Oswald et al., 2012)
and P2X receptors (Mankus et al., 2012, 2011; Mayo et al., 2008).
The expression of these receptors may provide a manner of inter-
dependent communication between the neurons and the corneal
cells in relation to wound healing; epithelium injured in vitro re-
leases ATP tomobilize a Ca2þwave to neighboring cells, but sensory
nerves are also required for proper wound closure in vivo. The
potential cross-talk between corneal epithelial cells and trigeminal
nerves was demonstrated in co-cultures under normoxic and
hypoxic conditions, as therewas a change in Ca2þ dynamic patterns
in epithelial cells when stimulated by wounded trigeminal nerves
exposed to hypoxic conditions (Lee et al., 2014).
Activation of purinergic receptors in corneal epithelial cells re-
sults in distinct post-translational modiﬁcation of the epidermal
growth factor receptor (EGFR) and structural proteins to link the
stimulus and signaling pathways leading to wound repair (Boucher
et al., 2011). P2Y2 mRNA expression increased during onset of cell
migration after injury and its knockdown attenuates Ca2þ mobili-
zation, phosphorylation of downstream molecules and cell migra-
tion (Fig. 3) (Boucher et al., 2010; Kehasse et al., 2013). For example
EGF stimulation yielded prototypical tyrosine phosphorylation on
EGFR, but ATP stimulation caused a 2- to 15-fold increase over
control in phosphorylation of EGFR Y974, Y1086, and Y1148 resi-
dues. Interestingly, ATP induced only minimal phosphorylation
intensity on EGFR Y1173 compared to that induced by EGF. Cells
cultured in stable isotope labeled amino acids followed by knock-
down of P2Y2 receptor revealed a signiﬁcant decrease in Src Y421
and paxillin Y118 with no change in EGFR Y1173. Together these
data indicate the far reaching importance of the P2Y2 receptor
(Kehasse et al., 2013).
While the P2Y2 receptor appears to be critical in modulating
downstream wound healing, the P2X7 receptor also modulates
integrity of the cornea. Altered stromal structure was detected in
the Pﬁzer P2X7/ mice (Mayo et al., 2008), with collagen ﬁbrils
individually thinner and lacking organization. While the two most
common collagen types, collagen a1(I) and collagen a3(V), were
decreased, collagen a1(III), a marker of corneal injury and scarring,
was increased. Likewise, lysyl oxidase expression increased, which
may contribute to the observed smaller ﬁbril diameters. Corneal
stromas in the P2X7/ mice also showed decreased expression of
the proteoglycans, decorin, keratocan, and lumican, which usually
facilitate collagen organization, and a decrease in overall proteo-
glycan sulfation. In contrast, perlecan, a heparan sulfate proteo-
glycan associated with wounding, increased throughout the
unwounded P2X7/ stroma. While in the wildtype, perlecan is
present along the basement membrane it was absent in the P2X7/
 corneas, which may explain the fragile epithelialestromal inter-
face. Digestion with keratanase I and chondroitinase ABC removed
more glycosaminoglycan side chains in the wildtype cornea, indi-
cating that the levels of undigested proteoglycans, which haveheparin sulfate side chains, are reciprocally regulated by P2X7
(Mankus et al., 2012). Altogether, these data suggest that the lack of
P2X7 holds the cornea in a pseudo-wounded state.
The human corneal epithelium expresses a splice variant in
addition to the full-length transcript of P2X7. While the variant
form is more prominent in subconﬂuent epithelium, it decreases as
the full-length form increases with polarization and stratiﬁcation.
This switch, accompanied by decreased proliferating cell nuclear
antigen (PCNA) and increased apical cell dye uptake, indicate that
corneal epithelial cells may respond to environmental changes
through P2X7 regulation (Mankus et al., 2011).
In conclusion, purines play a major regulatory role in the cornea
in cell communication and wound repair (Fig. 3). Future studies to
investigate how diabetes compromises purine-regulated cell
migration are currently underway and promise to add to the
complexities of pathophysiological actions of purines in the cornea.
2.3. Purine signaling in the trabecular meshwork: a modulator of
intraocular pressure
The purines ATP and adenosine have long been acknowledged to
modulate the ﬂow of aqueous humor. For example, adenosine
modulates intraocular pressure (IOP) by modifying both inﬂow and
outﬂow pathways of aqueous humor. Activation of A3 adenosine
receptors stimulates Cl channels of nonpigmented ciliary epithe-
lial cells, increasing inﬂow (Kiel et al., 2011) and IOP. Knockout of A3
adenosine receptors lowers IOP (Avila et al., 2002). In contrast, A1
adenosine receptor activation of trabecular meshwork (TM) cells
stimulates matrix metalloproteinase-2 and -9 (MMP-2,9) release,
reducing resistance through the trabecular outﬂow and lowering
IOP (Fig. 4). Inhibiting MMP activity abolishes A1-triggered resis-
tance reduction (Crosson et al., 2005). Adenosine can be delivered
to inﬂow and outﬂow cells by release and ectoenzymatic conver-
sion of ATP to adenosine. Six ecto-ATPases in native and immor-
talized human TM cells have been identiﬁed (Li et al., 2012b). These
enzymes are functional since ATP addition stimulates release of
zymographically-measured MMP-2 and MMP-9 (Li et al., 2012a).
Interrupting ATP conversion to adenosine abolishes ATP-triggered
MMP release.
Threemajor pathways of ATP release have been identiﬁed by the
luciferin-luciferase method during hypotonic swelling of TM cells
with/without inhibitors as shown in Fig. 4. Pannexin-1 (PX1)
hemichannels, connexin (Cx) hemichannels and P2X7 ATP iono-
tropic receptors (P2RX7) all are (Li et al., 2012b). Simultaneously
blocking PX1, Cx and P2RX7 abolishes swelling-activated ATP
release. Pharmacalogical evidence has been supplemented with
PX1-knockdown studies in TM cells by lentivirus-mediated RNA
interference. Partial knockdown reduced total swelling-activated
ATP release and reduced the efﬁcacy of the PX1 blocker probene-
cid, while enhancing the efﬁcacy of Cx and P2RX7 blockers, in
inhibiting ATP release. These knockdown results support the
pharmacologic results (Li et al., 2012b).
The ciliary epithelial cells responsible for aqueous humor inﬂow
also release ATP through PX1 and Cx hemichannels. However, ve-
sicular release, not P2RX7, provides the third major pathway for
swelling-activated ATP release (Li et al., 2012b). This difference may
permit differential delivery of ATP and adenosine to inﬂow and
outﬂow cells to alter IOP.
Six factors that can modulate TM-cell ATP-release have been
identiﬁed (Fig. 4). Like cell swelling, graded stretch of human TM
cells produces graded ATP release, with identical pharmacologic
proﬁle (Li et al., 2012b). As in other cells, the reducing agent
dithiothreitol inhibits PX1 and thereby ATP release, whereas non-
physiologic reductions in extracellular Ca2þ increase Cx hemi-
channel activity and ATP release (Li et al., 2012b). Increasing
Fig. 4. ATP release by trabecular meshwork cells. At least six modulators modify ATP
release through PX1, Cx and P2X7 channels (see Section 2.3). Enzymatic conversion of
released ATP to adenosine through ecto-nucleotide pyrophosphatase/phosphodies-
terases, ecto-nucleotide triphosphate diphosphohydrolases and ecto-5'-nucleotidase
initiates sequential: activation of A1 adenosine receptors, release of MMP-2 and -9, and
reductions of outﬂow resistance and IOP.
Fig. 5. Purinergic signaling in the lens. Swelling activates a TRPV4 receptor which in
turn activates ATP release from pannexin/connexin hemichannels. The released ATP
stimulates a P2Y receptor which activates the Na/K ATPase pump on the lens epithe-
lium to maintain lens transparency.
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TM or ciliary epithelial cells. In contrast, actin remodeling and
cardiotonic steroids (CTS) strongly alter ATP release. Incubation
(14 days) with dexamethasone markedly polymerizes actin, in-
creases cross-linked actin networks (CLANs) and inhibits swelling/
stretch-activated ATP release, whereas brief incubation with
cytochalasin-D depolymerizes actin and enhances swelling/
stretch-activated ATP release (Li et al., 2012b). The cytoskeleton-
dependent changes in ATP release are correlated with changes in
cell volume regulation. Finally, inhibiting Na,K ATPase with CTS
reduces swelling-activated ATP release, which is dissociable from
inhibiting Na/K-exchange through the Naþ pump, and is likely
mediated by the enzyme's scaffolding/signaling functions (Li et al.,
2012a). This inhibition may be physiologically relevant since
humans produce ouabain-like factors and express high-afﬁnity a2
Na,K ATPases in TM cells. Furthermore, selectively rendering a2 Naþ
pumps ouabain-resistant produces a knock-in mouse phenotype
(Schaefer et al., 2011).
2.4. Purines and the lens: response to osmotic stress
Lens transparency is the result of its unique cells. All but the
youngest lens ﬁbers lack organelles. Having no nucleus, ribosomes,
endoplasmic reticulum or mitochondria, fully differentiated lens
ﬁbers rely on the monolayer of epithelial cells that covers the
anterior surface of the ﬁber mass. Na,K-ATPase activity in epithelial
cells at the lens at the equator is critical to establishing a circulating
ﬂow of ions that underpins homeostasis of the entire ﬁber cell mass
(Mathias et al., 2007). Earlier studies point to the ability of puri-
nergic agonists ATP and UTP to increase Na,K-ATPase activity in lens
epithelium by a mechanism that hinges on activation of Src family
tyrosine kinases (Tamiya et al., 2007). The lens itself is capable of
releasing ATP and does so when subjected to hyposmotic stress. In
studies with intact porcine lens, osmolarity was reduced from 300
to 200 mOsm and within 10 min the concentration of ATP in the
bathing solution more than doubled (Shahidullah et al., 2012a). The
same hyposmotic stress also doubled Na,K-ATPase activity in the
lens epithelium and the change of Na,K-ATPase activity in the
epithelium was suppressed by maneuvers which interfered puri-
nergic receptors or stopped accumulation of extracellular ATP in
the medium.
Studies on themechanism of ATP release from the lens suggest it
occurs because connexin and pannexin hemichannels open. Therelative contribution of these two pathways has not been resolved:
a combination of 18a-glycyrrhetinic acid (AGA) (a connexin
blocker) added together with probenecid (PROB) (a pannexin
blocker) completely eliminated the ATP release but added alone,
AGA or PROB blocked only partially. The notion of a hemichannel
mechanism is reinforced by the ﬁnding that hyposmotic stress
opens a pathway for propidium iodide to gain entry to the lens
epithelium and this is prevented by AGA þ PROB. With a molecular
weight of 668, PI would be excluded by most channels but not
hemichannels. It is interesting that both increased PI uptake and
ATP release in hyposmotic solutionwere blocked by RN 1734, a very
different channel blocker that interferes with TRPV4 channels
(Shahidullah et al., 2012b). Moreover, it was found that PI entry into
the lens epitheliumwas increased by more than two-fold in lenses
exposed to a TRPV4 agonist GSK1016790A (GSK). We interpreted
these ﬁndings to signify activation of TRPV4 channels is a trigger for
hemichannel opening. In support of this idea, GSK was found to
trigger ATP release from the lens and the response was prevented
by AGA þ PROB. The observations are consistent with hyposmotic
stress-induced TRPV4 channel activation which triggers
hemichannel-mediated ATP release (Fig. 5). The results point to a
critical role for TRPV4 activation as trigger for hemichannel open-
ing and ATP release that serves to activate purinergic receptor-
dependent, Src kinase-dependent stimulation of Na,K-ATPase ac-
tivity. This chain of events may enable the lens to sense and
respond to hyposmotic stress.2.5. Diadenosine polyphosphates and the anterior eye: additional
endogenous agonists to modulate IOP, corneal wound healing and
tear formation
While the above sections have outlined the multiple effects of
ATP and adenosine signaling on the anterior eye, diadenosine
polyphosphates (abbreviated as ApnA) are also capable of stimu-
lating P2 receptors and have been demonstrated to modulate
several physiological processes in the anterior segment. Dia-
denosine polyphosphates are a distinct group of dinucleotide ag-
onists formed by two adenosine moieties linked by their ribose 5'-
ends to a number of phosphates, which can vary from 2 to 7 (see
Fig. 1). They are naturally occurring substances that can be released
to the extracellular medium bymeans of different mechanisms. The
action of these compounds is by means of P2 receptors as occurs
with other nucleotides. The most representative dinucleotides are
diadenosine tetraphosphate and diadenosine pentaphosphate,
Ap4A and Ap5A respectively.
It is known that ApnA are present in tears and that they can
stimulate tear secretion to 60% above normal tear values. This effect
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released as a consequence of the shear stress which occurs during
blinking (Peral et al., 2006). In addition, Ap4A is able to modify
protein tear composition. For instance, the levels of lysozyme in-
crease about 95% above normal values in rabbit tears when Ap4A is
instilled. Considering that lysozyme is one of the ﬁrst defence
mechanisms against bacterial infection, Ap4A is providing protec-
tion against pathogen invasion (Guzman-Aranguez et al., 2011).
Ap4A participates in other processes such as corneal wound
healing. In vivo experiments showed that Ap4A increased the rate of
healing by 130%. Consistent with this ﬁnding, the dinucleotide also
accelerated the rate of migration in primary cultures of rabbit
corneal epithelial cells. In both in vivo and in vitro cases, the actions
occur via P2Y2 receptors (Crooke et al., 2008). Ap4A is also a marker
for dry eye in pathologies such as evaporative and non-evaporative
dry eye, Sj€ogren syndrome and aniridia among other conditions
(Carracedo et al., 2010).
One interesting function of Ap4A is its ability to lower IOP, with
reductions of nearly 30% found (Guzman-Aranguez et al., 2007).
Pharmacological studies suggest that this hypotensive effect was
mediated by a P2X2 receptor. Moreover, denervation studies and
experimentswith anticholinergic agents localized the P2X2 receptor
to the cholinergic nerve terminals that innervate and control the
ciliary processes. Ap4A activates these P2X2 receptors, facilitating the
releaseofmore acetylcholine,which contracts themuscle pulling the
scleral spur, opening the irido-corneal angle and reducing hydrody-
namic resistance to theoutﬂow.Nevertheless, thehypotensive action
of Ap4A is not limited to these nerve endings and a direct effect of
Ap4A on the trabecularmeshwork has also been demonstrated. Ap4A
increased trabecular outﬂow facility in bovine ocular anterior seg-
ments by P2Y1 receptors activation. This indicates that Ap4A facili-
tates the drainage of the aqueous humor through the trabecular
meshwork, contributing to an IOP reduction (Guzman-Aranguez
et al., 2013). Another function has been recently proposed for Ap4A.
The application of Ap4A preserved the sympathetic terminals
innervating the ciliary body from 6-hydroxydopamine-induced
degeneration, indicating that this molecule has a neuroprotective
role that may be of interest in neurodegenerative diseases.
At present there is no direct evidence supporting any role for
diadenosine polyphosphates in the retina. Nonetheless, the dinu-
cleotide deoxycytidine tetraphosphouridine is able to enhance the
rate of subretinal ﬂuid reabsorption via P2Y2 receptor activation in
rodent models of retinal detachment (Guzman-Aranguez et al.,
2013) suggesting additional roles for the compounds in the poste-
rior eye are possible.
2.6. P2X receptors in retinal signaling: a role in modulating the
visual output
There is emerging evidence that purines can contribute to
neuromodulation in both the inner and outer retina (Fig. 6).
Expression of purinergic receptors, enzymes important for purine
degradation and the vesicular nucleotide transporter have all been
demonstrated (Puthussery and Fletcher, 2004, 2006, 2007). Double
labeling of P2X receptors with known markers of retinal neurons
has provided valuable information regarding the possible involve-
ment of purinergic receptors in retinal signaling. For example,
amacrine cells have either GABA or glycine as their predominate
amino acid neurotransmitters. Extensive colocalization of P2X2,
P2X3 and P2X7 receptors with GABA has been reported suggesting
that P2X receptors modulate information processing by GABAergic
amacrine cells (Puthussery and Fletcher, 2004, 2006, 2007).
Moreover, different P2X receptors are segregated to speciﬁc circuits
within the inner retina. Notably, P2X2 receptors are localized to
putative amacrine cells postsynaptic to cone bipolar cells and notrod bipolar cells, while P2X3 and P2X7 are localized to neurons
postsynaptic to both cone and rod bipolar cells. The neuronal cir-
cuitry subserving scotopic vision is well understood. In contrast to
the cone pathways (cones to cone bipolar cells to ganglion cells) the
rod pathway involves rod bipolar cells forming a synapse onto two
amacrine cells. With respect to purinergic receptors, A17 GABAergic
amacrine cell processes display immunoreactivity for both P2X3
and P2X7 and these receptors are localized at both conventional
and reciprocal synapses (Puthussery and Fletcher, 2004, 2007).
Although it is not knownwhether the same neuron expresses both
P2X receptor types, the results imply that GABA modulation of the
rod bipolar cell is more complex than hitherto thought, and that
purines acting on P2X3 and/or P2X7 receptors, may be important for
potentiating the release of GABA from A17 amacrine cells onto rod
bipolar cells.
P2X3 and P2X7 receptors have also been immunolocalized to the
outer plexiform layer. P2X7 has been localized presynaptically to rod
and cone pedicles, and functional studies have shown that BzATP
increases the amplitude of the a-wave (Puthussery and Fletcher,
2004). These results imply that P2X7 receptors have a role in regu-
lating photoreceptor function. The expression of P2X7 receptors by
photoreceptors may have important implications for photoreceptor
integrity. Indeed, intravitreal injection of ATP causes rapid loss of
photoreceptors, that can be reduced by co-injection with the P2X
antagonist, PPADS (Puthusseryand Fletcher, 2009). Treatmentof rd1
micewith PPADS reduced photoreceptor loss by approximately 30%
(Puthussery and Fletcher, 2009). This suggests that ATP release from
dying photoreceptors could affect the integrity of neighboring
photoreceptors, potentiating photoreceptor loss.
Purinergic signaling can also modulate visual signaling in the
inner retina. The complex synaptic processing potentially has an
outcome that affects visual information ﬂow, as RGC responses to
visual stimulation are modulated by P2X7 receptor activation with
BzATP or blockade by A438079 (Chavda et al., 2013). Whether this
reﬂects presynaptic P2X7 receptors or postsynaptic P2X7 receptors
located on retinal ganglion cells, or a combination of both, is still
unclear at present. This represents an avenue for further work, as
does the ﬁnding that these effects are paralleled by changes in
microglial morphology (Chavda et al., 2013).
2.7. Purinergic signaling in Müller cells: a role in volume regulation
Müller cells are the principal macroglial cells of the retina, with
numerous ﬁne processes emanating from central stems that span
the whole thickness of the retina. These processes place them in
intimate contact bothwith neurons and non-neural structures such
as blood vessels, the vitreous and the subretinal space (Fig. 7). This
intimate interaction makes Müller cells ideally located to fulﬁll
several crucial functions in maintaining the integrity of retinal
tissue. For example, Müller cells mediate neurovascular coupling,
perform neurotransmitter recycling, support the neuronal energy
metabolism and maintain the retinal ion- and volume homeostasis
(Reichenbach and Bringmann, 2013).
Recent studies point to a key role of purinergic signaling in
Müller cell function (Wurm et al., 2011). Retinal neurons and glial
cells are endowed with various purinergic receptors enabling them
to react to extracellular purines such as ATP, ADP or adenosine. The
principal ATP-sensitive receptor on Müller cells is the P2Y1-recep-
tor, coupling to Gq11, while ionotropic P2X receptors appear to be
largely absent from the Müller cells (Wurm et al., 2009). P2Y1-
activation is primarily responsible for elevations in intracellular
calcium levels seen in response to ATP application in juvenile and
differentiated adult Müller cells. Moreover, a complex
glutamatergic-purinergic signaling cascade involving the P2Y1-re-
ceptor metabotropic glutamate receptors, ATP release, the P2Y1
Fig. 6. Purines in the retina in signaling and pathology. Schematic diagram illustrating the mechanisms highlighted in the present review. On the left, pathways involved in the
transmission of the visual signal, with P2X7 receptors both increasing the a-wave and modulating the response to light by RGCs (see Section 2.6). Purines help Müller cells maintain
their volume and the ﬂuid balance of the retina, contributing to both signal transmission and pathophysiological outcomes (see Section 2.7 and Fig. 7). With regards to the role of
purines in retinal pathophysiology, ATP acting at P2X7 receptors can raise Ca2þ and kill RGCs, while conversion to adenosine can temper this (Section 2.8). Likewise, ATP released
from RPE cells can autostimulate P2X7 receptors to raise lysosomal pH and increase lipofuscin-like autoﬂuorescence while adenosine acting at A2A receptors can reacidify
compromised lysosomes and reduce autoﬂuorescence (Section 2.9).
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maintain their cell volume. In contrast, bipolar cells do not possess
comparable mechanisms of volume regulation and swell under
hypoosmotic conditions; purines have no effect on the swelling
behavior of bipolar cells (Vogler et al., 2013).
Tight cellular volume regulation is a prerequisite for Müller cells
to mediate transcellular ion- and ﬂuid ﬂuxes from the extracellular
space of the retina to reservoirs like the vitreous body or blood
vessels; this in turn enables the spatial buffering of potassium the
and maintenance of retinal ﬂuid homeostasis (Reichenbach and
Bringmann, 2013). While volume regulation is limited in Müller
cell progenitors and in dedifferentiated gliotic Müller cells found in
pathologically altered retina (after ischemia or diabetic retinop-
athy), this regulation can be improved by stimulation of P2Y1 re-
ceptors or A1 adenosine receptors (Wurm et al., 2009, 2008). Loss of
volume regulation from Müller cells may contribute to retinal
edema, as can occur in the diabetic retina. As such, the restoration
of regulatory capabilities by activation of purinergic receptors
should be considered when thinking about new therapeutic stra-
tegies to resolve retinal edema.2.8. P2X7 receptors and neurodegeneration of retinal ganglion cells
Retinal ganglion cells (RGCs) express multiple P2 and adenosine
receptors. This abundance of receptors in the healthy eye indirectly
implies an important physiological contribution from the puriner-
gic signaling system. While our understanding of these physio-
logical roles is emerging, (as discussed in Section 2.6. above), much
of the research in relation to purines and RGCs has focused on the
P2X7 receptor and its potential role in neurodegeneration. This is a
key area of interest since RGC degeneration is central to the path-
ophysiology of glaucoma, and neuroprotection is a major thera-
peutic goal.
Stimulation of the P2X7 receptor with the agonist BzATP
induced death of isolated RGCs via an increase in intracellular Ca2þ
and activation of caspase (Zhang et al., 2005), while intravitreal
injection of BzATP resulted in RGCs loss in vivo (Hu et al., 2010). In
both cases RGC death was prevented by P2X7 receptor antagonists.
More recently, P2X7-mediated RGC death was demonstrated in an
in vivo optic nerve crush model (Kakurai et al., 2013) and in human
retinal explants (Niyadurupola et al., 2011, 2013). Together, these
Fig. 7. The contribution of purines to Müller cell volume regulation. Growth factors
acting directly on Müller glia trigger sequential glutamate (via exocytosis) and ATP (via
hemichannels) release. ATP acts at P2Y1 receptors after dephosphorylation to ADP by
ectonucleotidase NTPDase2. The adenosine released stimulated A1-receptors and ini-
tiates the opening of Cl and Kþ channels; this efﬂux of ions osmotically draws water
out of the cell, reducing cell volume and balancing retinal ﬂuid levels (See Section 2.7).
Transport across the RPE and spatial buffering of Kþ across the inner retina add to
maintaining ﬂuid balance. BV, blood vessel; NT, nucleoside transporter, 5'NT, 5'-ecto-
nucleotidase, mGluR, metabotropic glutamate receptor.
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pathological loss of RGCs (Fig. 6). Of particular note is the ability of
P2X7 receptor antagonists to prevent RGC death triggered by
simulated ischemia (oxygen and glucose deprivation) in a human
retinal explant model (Niyadurupola et al., 2013). This suggests that
metabolic stress may cause release of ATP which can trigger P2X7
receptor-mediated excitotoxicity.
The adenosine produced by dephosphorylation of extracellular
ATP may balance the pathological effects of the P2X7 receptor on
RGCs. Adenosine directly modulates RGC function and confers
general neuroprotection via the A1 receptors (Hartwick et al., 2004;
Newman, 2004), with A3 adenosine receptors speciﬁcally pre-
venting the damage induced by the P2X7 receptor (Zhang et al.,
2006). Recent evidence for the mechanosensitive release of ATP
from optic nerve head astrocytes via pannexin hemichannels,
coupled with the ability of stretch to increase expression of several
pannexin isoforms both in vitro and in the optic nerve head of 8
month old Tg-MyocY437H mice provides a mechanism for ampli-
fying levels of extracellular ATP in chronic glaucoma (Beckel et al.,
2014).2.9. Purinergic signaling and lipofuscin in RPE cells
In RPE cells, as in other ocular tissues, the mechanisms leading
to ATP release, and the regulation of enzymes responsible for
dephosphorylating ATP into adenosine, provide the goalposts that
ultimately control the extent and duration of purinoreceptor
stimulation. The relative levels of purines and pyrimidines deter-
mined by release and degradation ultimately dictate the availability
of agonists capable of stimulating the P2X, P2Y and adenosine re-
ceptors present on RPE cells (Mitchell and Reigada, 2008). While
ATP release and subsequent dephosphorylation to ADP, AMP and
adenosine seem to follow the general patterns, two observations
may be of relevance to signaling in RPE cells.
The ﬁrst point relates to the rapid release of ATP from swollen
RPE cells (Mitchell, 2001). While cell swelling is a standard tool
used to study ATP release, RPE cells are generally not associated
with large changes in cell volume. However, RPE cell hypertrophy is
widespread in several retinal degenerations and swelling could
lead to a chronic increase in ATP release. The increased expression
of a marker for extracellular ATP in RPE cells of the ABCA4/
mouse model of Stargardt's retinal degeneration is consistent with
this theory (Guha et al., 2013).
Secondly, the balance between extracellular ATP and adenosine
may alter the lysosomal activity of RPE cells and thus inﬂuence the
production of lipofuscin (Fig. 6). Stimulation of the P2X7 receptor
raises lysosomal pH in RPE cells and slowes autophagic turnover,
modifying levels of p62 and the LC3Bll/LC3Bl ratio (Guha et al.,
2013). RPE cells fed photoreceptor outer segments displayed a
lipofuscin-like autoﬂuorescence upon lysosomal alkalinization, but
blockage of the P2X7 receptor reduced this autoﬂuorescence. The
ability of lysosomal alkalinization to increase levels of lipid oxida-
tion, and of P2X7 antagonism to reduce this lipid oxidation are of
particular interest. The action of P2X7 antagonists to reduce levels
of both lipofuscin and oxidized lipid is particularly striking as no
exogenous agonist was added. This suggests that the release of
endogenous ATP fromRPE cells can autostimulate P2X7 receptors to
alkalinize lysosomes, oxidize lipids and increase lipofuscin levels.
In contrast to the actions of the P2X7 receptor, the adenosine A2A
receptor can reacidify compromised lysosomes and reduce levels of
photoreceptor outer segment autoﬂuorescence (Liu et al., 2008).
The elevation of cytoplasmic cAMP following stimulation of the
adenosine A2A receptor likely underlies this restoration of acidic
lysosomal pH. Together, this implies that conversion of released
ATP into adenosine by ectoenzymes may inﬂuence the production
of lipofuscin and lipid oxidation in RPE cells (Guha et al., 2014).
Whether the balance between ATP and adenosine inﬂuences the
progression of diseases like age-related macular degeneration re-
mains to be seen.
3. Conclusion
It is clear that ATP, adenosine and diadenosine polyphosphates
have complex actions in the eye, and newly discovered functions are
expected to add to this complexity. Even if most of the transmitter
responsible for activating the receptors comes from local release, it is
still remarkable that the actions of released purines remain conﬁned
to the desired target tissue. While the ectoATPDases, ectonucleoti-
dases andother enzymes are highlyeffective at keeping purine levels
low inmostexperimental conditions, thepresenceof somany tissues
capable of ATP release combined with a plethora of purinergic re-
ceptors in the eye suggest a possibility for off-target actions, partic-
ularly if excessive release occurs under pathological or inﬂammatory
conditions. Future directions may indicate whether interactions be-
tween the purinergic signaling systems of distinct ocular regions
discussed above can contribute to problems in eye disease.
J. Sanderson et al. / Experimental Eye Research 127 (2014) 270e279278Acknowledgments
This research was supported by grants from the National Insti-
tute of Health EY013434 (CHM) EY015537 (CHM) EY009532 (NAD)
EY06915 (NAD) EY013624 (MMC) EY01583 (MMC & CHM)
EY006177 (DAD) EY06000 (VTR), EY06000S (VTR), New England
Corneal Transplant Fund (VTR) Ophthalmology Departmental grant
from Massachusetts Lions Eye Research Fund, Inc (VTR), The Hu-
mane Research Trust (JS), The Norwich Glaucoma Research Fund
(JS), Universidad Complutense de Madrid Project GR35/10-A-
920777 (JP), the Ministry of Economy SAF 2010/16024 (JP), Institute
Carlos III Redes tematicas de investigacion cooperativa en salud
RD12/0034/0003 (JP), the Jody Sack Fund (CHM), the DFG GR4403/
1-1 (AG), FOR 748 (AG), PRO RETINA Deutschland e. V. (AG). The
authors would like to acknowledge contributions of J Banerjee, S
Chavda, CT Leung, M Leonard, A Li, KL Li, W Lu, PJ Luthert, M Sha-
hidullah and WD Stamer. CHM has IP that relates to some of the
topics discussed above.References
Avila, M.Y., Stone, R.A., Civan, M.M., 2002. Knockout of A3 adenosine receptors re-
duces mouse intraocular pressure. Investig. Ophthalmol. Vis. Sci. 43,
3021e3026.
Beckel, J.M., Argall, A.J., Lim, J.C., Xia, J., Lu, W., Coffey, E.E., Macarak, E.J.,
Shahidulla, M., Delamere, N.A., Zode, G.S., Shefﬁeld, V.C., Laties, A.M.,
Mitchell, C.H., 2014. Mechanosensitive release of ATP through pannexin chan-
nels and mechanosensitive upregulation of pannexin channels in optic nerve
head astrocytes: a mechanism for purinergic involvement in chronic strain. Glia
46, 1486e1501.
Boucher, I., Kehasse, A., Marcincin, M., Rich, C., Rahimi, N., Trinkaus-Randall, V.,
2011. Distinct activation of epidermal growth factor receptor by UTP contributes
to epithelial cell wound repair. Am. J. Pathol. 178, 1092e1105.
Boucher, I., Rich, C., Lee, A., Marcincin, M., Trinkaus-Randall, V., 2010. The P2Y2
receptor mediates the epithelial injury response and cell migration. Am. J.
Physiol. Cell Physiol. 299, C411eC421.
Burnstock, G., 2006. Pathophysiology and therapeutic potential of purinergic
signaling. Pharmacol. Rev. 58, 58e86.
Carracedo, G., Peral, A., Pintor, J., 2010. Diadenosine polyphosphates in tears of
Sjogren syndrome patients. Investig. Ophthalmol. Vis. Sci. 51, 5452e5459.
Chavda, S., Luthert, P.J., Salt, P.E., 2013. P2X7 receptor activation modulates light-
evoked retinal ganglion cell synaptic responses and microglial morphology.
Soc. Neurosci. Abstr. 553, 513.
Corriden, R., Insel, P.A., 2010. Basal release of ATP: an autocrine-paracrine mecha-
nism for cell regulation. Sci. Signal. 3, re1.
Crooke, A., Guzman-Aranguez, A., Peral, A., Abdurrahman, M.K., Pintor, J., 2008.
Nucleotides in ocular secretions: their role in ocular physiology. Pharmacol.
Ther. 119, 55e73.
Crosson, C.E., Sloan, C.F., Yates, P.W., 2005. Modulation of conventional outﬂow
facility by the adenosine A1 agonist N6-cyclohexyladenosine. Investig. Oph-
thalmol. Vis. Sci. 46, 3795e3799.
Dartt, D.A., 2009. Neural regulation of lacrimal gland secretory processes: relevance
in dry eye diseases. Prog. Retin. Eye Res. 28, 155e177.
Dartt, D.A., Hodges, R.R., 2011a. Cholinergic agonists activate P2X7 receptors to
stimulate protein secretion by the rat lacrimal gland. Investig. Ophthalmol. Vis.
Sci. 52, 3381e3390.
Dartt, D.A., Hodges, R.R., 2011b. Interaction of alpha1D-adrenergic and P2X(7) re-
ceptors in the rat lacrimal gland and the effect on intracellular [Ca2þ] and
protein secretion. Investig. Ophthalmol. Vis. Sci. 52, 5720e5729.
Fitz, J.G., 2007. Regulation of cellular ATP release. Trans. Am. Clin. Climatol. Assoc.
118, 199e208.
Guha, S., Baltazar, G.C., Coffey, E.E., Tu, L.-A., Lim, J.C., Beckel, J.M., Eysteinsson, T.,
Lu, W., O'Brien-Jenkins, A., Patel, S., Laties, A.M., Mitchell, C.H., 2013. Lysosomal
alkalinization, lipid oxidation, impaired autophagy and reduced phagosome
clearance triggered by P2X7 receptor activation in retinal pigmented epithelial
cells. Faseb J. 27, 4500e4509.
Guha, S., Coffey, E.E., Lu, W., Lim, J.C., Beckel, J.M., Laties, A.M., Mitchell, C.H., 2014.
Approaches for detecting lysosomal alkalinization and impaired degradation in
fresh and cultured RPE cells: evidence for a role in retinal degenerations. Exp.
Eye Res. 68e76.
Guzman-Aranguez, A., Crooke, A., Peral, A., Hoyle, C.H., Pintor, J., 2007. Dinucleoside
polyphosphates in the eye: from physiology to therapeutics. Prog. Retin. Eye
Res. 26, 674e687.
Guzman-Aranguez, A., Loma, P., Pintor, J., 2011. Focus on molecules: diadenosine
tetraphosphate. Exp. Eye Res. 92, 96e97.
Guzman-Aranguez, A., Santano, C., Martin-Gil, A., Fonseca, B., Pintor, J., 2013. Nu-
cleotides in the eye: focus on functional aspects and therapeutic perspectives.
J. Pharmacol. Exp. Ther. 345, 331e341.Hartwick, A.T., Lalonde, M.R., Barnes, S., Baldridge, W.H., 2004. Adenosine A1-
receptor modulation of glutamate-induced calcium inﬂux in rat retinal gan-
glion cells. Investig. Ophthalmol. Vis. Sci. 45, 3740e3748.
Hodges, R.R., Vrouvlianis, J., Scott, R., Dartt, D.A., 2011. Identiﬁcation of P2X(3) and
P2X(7) purinergic receptors activated by ATP in rat lacrimal gland. Investig.
Ophthalmol. Vis. Sci. 52, 3254e3263.
Hodges, R.R., Vrouvlianis, J., Shatos, M.A., Dartt, D.A., 2009. Characterization of P2X7
purinergic receptors and their function in rat lacrimal gland. Investig. Oph-
thalmol. Vis. Sci. 50, 5681e5689.
Hu, H.L., Lu, W.N., Zhang, M., Zhang, X.L., Argall, A.J., Patel, S., Lee, G.E., Kim, Y.C.,
Jacobson, K.A., Laties, A.M., Mitchell, C.H., 2010. Stimulation of the P2X(7) re-
ceptor kills rat retinal ganglion cells in vivo. Exp. Eye Res. 91, 425e432.
Kakurai, K., Sugiyama, T., Kurimoto, T., Oku, H., Ikeda, T., 2013. Involvement of
P2X(7) receptors in retinal ganglion cell death after optic nerve crush injury in
rats. Neurosci. Lett. 534, 237e241.
Kehasse, A., Rich, B., Lee, A., McComb, M., Costello, C.E., Trinkaus-Randall, V., 2013.
Epithelial wounds induce differential phosphorylation changes in response to
purinergic and EGF receptor activation. Am. J. Pathol. 183, 1841e1852.
Kiel, J.W., Hollingsworth, M., Rao, R., Chen, M., Reitsamer, H.A., 2011. Ciliary blood
ﬂow and aqueous humor production. Prog. Retin. Eye Res. 30, 1e17.
Lee, A., Derricks, K., Minns, M., Ji, S., Chi, C., Nugent, M.A., Trinkaus-Randall, V., 2014.
Hypoxia-induced changes in Ca2þ mobilization and protein phosphorylation
implicated in impaired wound healing. Am. J. Physiol. Cell Physiol. 306,
C972eC985.
Li, A., Banerjee, J., Peterson-Yantorno, K., Stamer, W.D., Leung, C.T., Civan, M.M.,
2012a. Effects of cardiotonic steroids on trabecular meshwork cells: search for
mediator of ouabain-enhanced outﬂow facility. Exp. Eye Res. 96, 4e12.
Li, A., Leung, C.T., Peterson-Yantorno, K., Stamer, W.D., Mitchell, C.H., Civan, M.M.,
2012b. Mechanisms of ATP release by human trabecular meshwork cells, the
enabling step in purinergic regulation of aqueous humor outﬂow. J. Cell.
Physiol. 227, 172e182.
Liu, J., Lu, W., Reigada, D., Nguyen, J., Laties, A.M., Mitchell, C.H., 2008. Restoration of
lysosomal pH in RPE cells from cultured human and ABCA4(-/-) mice: phar-
macologic approaches and functional recovery. Investig. Ophthalmol. Vis. Sci.
49, 772e780.
Mankus, C., Chi, C., Rich, C., Ren, R., Trinkaus-Randall, V., 2012. The P2X(7) re-
ceptor regulates proteoglycan expression in the corneal stroma. Mol. Vis. 18,
128e138.
Mankus, C., Rich, C., Minns, M., Trinkaus-Randall, V., 2011. Corneal epithelium ex-
presses a variant of P2X(7) receptor in health and disease. PLoS One 6, e28541.
Mathias, R.T., Kistler, J., Donaldson, P., 2007. The lens circulation. J. Membr. Biol. 216,
1e16.
Mayo, C., Ren, R., Rich, C., Stepp, M.A., Trinkaus-Randall, V., 2008. Regulation by
P2X7: epithelial migration and stromal organization in the cornea. Investig.
Ophthalmol. Vis. Sci. 49, 4384e4391.
Mitchell, C.H., 2001. Release of ATP by a human retinal pigment epithelial cell line:
potential for autocrine stimulation through subretinal space. J. Physiol. 534,
193e202.
Mitchell, C.H., Reigada, D., 2008. Purinergic signalling in the subretinal space: a role
in the communication between the retina and the RPE. Purinergic Signal 4,
101e107.
Newman, E.A., 2004. Glial modulation of synaptic transmission in the retina. Glia
47, 268e274.
Niyadurupola, N., Sidaway, P., Ma, N., Rhodes, J.D., Broadway, D.C., Sanderson, J.,
2013. P2X7 receptor activation mediates retinal ganglion cell death in a human
retina model of ischemic neurodegeneration. Investig. Ophthalmol. Vis. Sci. 54,
2163e2170.
Niyadurupola, N., Sidaway, P., Osborne, A., Broadway, D.C., Sanderson, J., 2011. The
development of human organotypic retinal cultures (HORCs) to study retinal
neurodegeneration. Br. J. Ophthalmol. 95, 720e726.
Notomi, S., Hisatomi, T., Kanemaru, T., Takeda, A., Ikeda, Y., Enaida, H., Kroemer, G.,
Ishibashi, T., 2011. Critical involvement of extracellular ATP acting on P2RX7
purinergic receptors in photoreceptor cell death. Am. J. Pathol. 179, 2798e2809.
Novak, I., Jans, I.M., Wohlfahrt, L., 2010. Effect of P2X(7) receptor knockout on
exocrine secretion of pancreas, salivary glands and lacrimal glands. J. Physiol.
588, 3615e3627.
Oswald, D.J., Lee, A., Trinidad, M., Chi, C., Ren, R., Rich, C.B., Trinkaus-Randall, V.,
2012. Communication between corneal epithelial cells and trigeminal neurons
is facilitated by purinergic (P2) and glutamatergic receptors. PLoS One 7,
e44574.
Pearson, R.A., Dale, N., Llaudet, E., Mobbs, P., 2005. ATP released via gap junction
hemichannels from the pigment epithelium regulates neural retinal progenitor
proliferation. Neuron 46, 731e744.
Peral, A., Carracedo, G., Acosta, M.C., Gallar, J., Pintor, J., 2006. Increased levels of
diadenosine polyphosphates in dry eye. Invest. Ophthalmol. Vis. Sci. 47,
4053e4058.
Puthussery, T., Fletcher, E., 2009. Extracellular ATP induces retinal photoreceptor
apoptosis through activation of purinoceptors in rodents. J. Comp. Neurol 513,
430e440.
Puthussery, T., Fletcher, E.L., 2004. Synaptic localization of P2X7 receptors in the rat
retina. J. Comp. Neurol 472, 13e23.
Puthussery, T., Fletcher, E.L., 2006. P2X2 receptors on ganglion and amacrine cells in
cone pathways of the rat retina. J. Comp. Neurol 496, 595e609.
Puthussery, T., Fletcher, E.L., 2007. Neuronal expression of P2X3 purinoceptors in
the rat retina. Neuroscience 146, 403e414.
J. Sanderson et al. / Experimental Eye Research 127 (2014) 270e279 279Reichenbach, A., Bringmann, A., 2013. New functions of Muller cells. Glia 61,
651e678.
Schaefer, T.L., Lingrel, J.B., Moseley, A.E., Vorhees, C.V., Williams, M.T., 2011. Targeted
mutations in the Na,K-ATPase alpha 2 isoform confer ouabain resistance and
result in abnormal behavior in mice. Synapse 65, 520e531.
Shahidullah, M., Mandal, A., Beimgraben, C., Delamere, N.A., 2012a. Hyposmotic
stress causes ATP release and stimulates Na,K-ATPase activity in porcine lens.
J. Cell. Physiol. 227, 1428e1437.
Shahidullah, M., Mandal, A., Delamere, N.A., 2012b. TRPV4 in porcine lens epithe-
lium regulates hemichannel-mediated ATP release and Na-K-ATPase activity.
Am. J. Physiol. Cell Physiol. 302, C1751eC1761.
Sugiyama, T., Kawamura, H., Yamanishi, S., Kobayashi, M., Katsumura, K., Puro, D.G.,
2005. Regulation of P2X7-induced pore formation and cell death in pericyte-
containing retinal microvessels. Am. J. Physiol. Cell Physiol. 288, C568eC576.
Tamiya, S., Okafor, M.C., Delamere, N.A., 2007. Purinergic agonists stimulate lens Na-
K-ATPase-mediated transport via a Src tyrosine kinase-dependent pathway.
Am. J. Physiol. Cell Physiol. 293, C790eC796.
Vogler, S., Grosche, A., Pannicke, T., Ulbricht, E., Wiedemann, P., Reichenbach, A.,
Bringmann, A., 2013. Hypoosmotic and glutamate-induced swelling of bipolarcells in the rat retina: comparison with swelling of Muller glial cells.
J. Neurochem. 126, 372e381.
Wurm, A., Erdmann, I., Bringmann, A., Reichenbach, A., Pannicke, T., 2009.
Expression and function of P2Y receptors on Muller cells of the postnatal rat
retina. Glia 57, 1680e1690.
Wurm, A., Iandiev, I., Hollborn, M., Wiedemann, P., Reichenbach, A.,
Zimmermann, H., Bringmann, A., Pannicke, T., 2008. Purinergic receptor acti-
vation inhibits osmotic glial cell swelling in the diabetic rat retina. Exp. Eye Res.
87, 385e393.
Wurm, A., Pannicke, T., Iandiev, I., Francke, M., Hollborn, M., Wiedemann, P.,
Reichenbach, A., Osborne, N.N., Bringmann, A., 2011. Purinergic signaling involved
inMuller cell function in themammalian retina. Prog. Retin. Eye Res. 30, 324e342.
Zhang, X., Zhang, M., Laties, A.M., Mitchell, C.H., 2005. Stimulation of P2X7 receptors
elevates Ca2þ and kills retinal ganglion cells. Investig. Ophthalmol. Vis. Sci. 46,
2183e2191.
Zhang, X., Zhang, M., Laties, A.M., Mitchell, C.H., 2006. Balance of purines may
determine life or death of retinal ganglion cells as A3 adenosine receptors
prevent loss following P2X7 receptor stimulation. J. Neurochem. 98, 566e575.
